2020
DOI: 10.1134/s1990750820040113
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the Levels of Metabolites in Feces of Patients with Inflammatory Bowel Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…The content of SCFAs in feces is becoming an important clinical indicator to judge the intestinal health status of patients with IBDs, which include UC and Crohn's disease (Zhgun et al, 2020). Low levels of SCFAs may lead to a series of problems such as reduced intestinal peristalsis, barrier dysfunction, and excessive inflammation (Parada Venegas et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…The content of SCFAs in feces is becoming an important clinical indicator to judge the intestinal health status of patients with IBDs, which include UC and Crohn's disease (Zhgun et al, 2020). Low levels of SCFAs may lead to a series of problems such as reduced intestinal peristalsis, barrier dysfunction, and excessive inflammation (Parada Venegas et al, 2019).…”
Section: Discussionmentioning
confidence: 99%